Erez Aminov - 21 May 2024 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Chief Executive Officer, Director
Signature
/s/ Michelle Yanez, Attorney-in-Fact for Erez Aminov
Issuer symbol
MIRA
Transactions as of
21 May 2024
Net transactions value
+$8,176
Form type
4
Filing time
22 May 2024, 17:42:53 UTC
Previous filing
27 Mar 2024
Next filing
30 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRA Common Stock Purchase $2,000 +2,000 +0.54% $1.00 375,500 21 May 2024 Direct F1
transaction MIRA Common Stock Purchase $1,030 +1,000 +0.27% $1.03 376,500 21 May 2024 Direct F1
transaction MIRA Common Stock Purchase $510 +500 +0.13% $1.02 377,000 21 May 2024 Direct F1
transaction MIRA Common Stock Purchase $1,680 +2,000 +0.53% $0.8400 379,000 21 May 2024 Direct F1
transaction MIRA Common Stock Purchase $850 +1,000 +0.26% $0.8500 380,000 21 May 2024 Direct F1
transaction MIRA Common Stock Purchase $522 +600 +0.16% $0.8700 380,600 21 May 2024 Direct F1
transaction MIRA Common Stock Purchase $808 +800 +0.21% $1.01 381,400 21 May 2024 Direct F1
transaction MIRA Common Stock Purchase $776 +800 +0.21% $0.9700 382,200 21 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are directly owned by Mr. Aminov.